PL EN
  1. www.sciencepharma.pl
  2. Aktualności
  3. URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of May 04, 2015 concerning the avoidance of prescribing certain drugs including hepatitis C and amiodarone

URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of May 04, 2015 concerning the avoidance of prescribing certain drugs including hepatitis C and amiodarone

14.05.2015
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of May 04, 2015 concerning the avoidance of prescribing certain drugs including hepatitis C and amiodarone.
Źródło wiadomośći: http://www.urpl.gov.pl/aktualnosci/informacja-z-dnia-04-05-2015-r-w-sprawie-unikania-przepisywania-lacznie-niektorych-lekow-na-zapalenie-watroby-typu-c-i-amiodaronu

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny